Format

Send to

Choose Destination
Clin Exp Rheumatol. 1999 Jan-Feb;17(1):88-90.

Periarticular corticosteroid treatment of the sacroiliac joint in patients with seronegative spondylarthropathy.

Author information

1
Satalinna Hospital, Harjavalta and Rheumatism Foundation Hospital, Heinola, Finland.

Abstract

OBJECTIVE:

To evaluate the efficacy of periarticular corticosteroid injection of the sacroiliac joint (SIJ) in patients with seronegative spondylarthropathy in a double blind, controlled study.

METHODS:

20 patients with seronegative spondylarthropathy and clinical sacroiliitis entered the study. In 10 patients one affected SIJ was treated with periarticular injection of 1.5 ml (40 mg/ml) methylprednisoloneacetate and 1.5 ml (20 mg/ml) lignocaine (MP group), whereas 10 patients received 1.5 ml isotonic sodium chloride and 1.5 ml (20 mg/ml) lignocaine (non-MP group). Clinical assessment at the onset of the study and after two months follow-up included the patients' estimation of pain in the SIJ by the visual analogue scale (VAS) and by a pain index which was calculated from tenderness and stressing tests on the SIJ.

RESULTS:

At the two months follow-up examination the VAS (p = 0.02) and the pain index (p = 0.01) had improved significantly in the MP group compared with the non-MP group.

CONCLUSION:

The results of our study indicate that the periarticular injection of methylprednisolone may be effective in the treatment of clinical sacroiliitis in patients with seronegative spondylarthropathy.

PMID:
10084038
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center